Literature DB >> 16704848

Historical Lassa fever reports and 30-year clinical update.

Abe M Macher1, Martin S Wolfe.   

Abstract

Five cases of Lassa fever have been imported from West Africa to the United States since 1969. We report symptoms of the patient with the second imported case and the symptoms and long-term follow-up on the patient with the third case. Vertigo in this patient has persisted for 30 years.

Entities:  

Mesh:

Year:  2006        PMID: 16704848      PMCID: PMC3374442          DOI: 10.3201/eid1205.050052

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Lassa fever is a viral hemorrhagic fever caused by a rodentborne arenavirus that is endemic in West Africa. In 2004, the Centers for Disease Control and Prevention (CDC) reported a fatal case of Lassa fever in New Jersey (). CDC noted that ≈20 imported cases of Lassa fever had been seen outside West Africa. Five patients with imported disease have been hospitalized in the United States (Table). We report the signs and symptoms of the second patient in this group of 5 patients and the signs and symptoms and long-term follow-up of the third patient, both aid workers who became ill in 1975 while serving in Sierra Leone. Their clinical courses were complicated by severe neurologic dysfunction, including unilateral sensorineural deafness and vertigo. *Patients 1–4 are US citizens; patient 5 is a Liberian national.

Case 1

In February 1975, a 26-year-old American aid worker in Sierra Leone was hospitalized with severe abdominal pain. No cause was determined, and she was discharged. In March 1975, watery diarrhea, fever, chills, headache, myalgias, arthralgias, and conjunctival injection developed. She was hospitalized, and physical examination showed posterior cervical, axillary, and inguinal lymphadenopathy. She was empirically treated for malaria and amebiasis. Nevertheless, fever persisted, she lost 2.7 kg, and pleuritic chest pain developed. In April 1975, she was air evacuated and admitted to a hospital in Washington, DC. Although she was afebrile, generalized lymphadenopathy was still present, and a chest radiograph showed left-sided pleural effusion. Thoracentesis fluid was remarkable for eosinophilia, and examinations of blood showed 3%–35% peripheral eosinophilia. Knott's preparation of blood showed 3 sheathed microfilariae with nuclei extending into the tail, presumed to be Loa loa. A cervical lymph node biopsy showed follicular hyperplasia. She was convalescing in the hospital when suddenly, while speaking on the telephone, she lost hearing unilaterally. An audiogram demonstrated unilateral sensorineural deafness. A serum specimen collected in May 1975 was sent to CDC, where an indirect fluorescent antibody (IFA) titer of 256 was demonstrated against Lassa fever virus (P. Rollin, pers. comm.). She was discharged with residual unilateral deafness.

Case 2

In December 1975, abdominal cramps, nausea, vomiting, diarrhea, fatigue, headaches, retroorbital pain, aching shoulders, and severe low back pain developed in a 43-year-old American aid worker in Sierra Leone.1 Her aching progressed to total body pain, which she described as "severe pain in her bones, as if they were breaking" (from patient's medical chart). Her symptoms persisted, and in February 1976, nocturnal fevers and sweats developed. She experienced dizziness and syncope and was hospitalized. She was hypotensive with blood pressure as low as 70/40 mm Hg (compared to 120/80 mm Hg in June 1975) and had insomnia. She was empirically treated for malaria and discharged. Her symptoms reappeared, accompanied by persistent vomiting, shooting pain in the right ear, neck pain, paresthesias, and alopecia. She lost 4 kg. In March 1976, she was air evacuated and admitted to a hospital in Washington, DC. During her hospitalization in Washington, she was afebrile. However, fatigue, headache, neck pain, nausea, low back pain, and insomnia persisted. She had costochondral and diffuse abdominal tenderness and ecchymoses at intramuscular injection sites (antiemetics). She was unable to read for more than a few minutes, as her eyes would tire and begin to hurt. She experienced dysmorphopsias, difficulty with hearing, severe depression, and numerous episodes of lightheadedness, unsteadiness, dizziness, and vertigo. Vertigo occurred in both supine and standing positions up to 5 times per day. Although she was hypotensive, she was not orthostatic. Neurologic examination found left-sided facial weakness, right-sided Babinski reflex, and the Weber test lateralized to the left. Audiometry and positional and caloric nystagmography results were unremarkable. A serum specimen obtained on March 1 showed an IFA titer of 64 against Lassa virus. Lassa virus was recovered from a March 3 urine specimen. On March 10, a serum specimen demonstrated a complement fixation antibody titer of 16, a 4-fold rise compared to a titer <4 in a February 25 specimen drawn in Sierra Leone. Although her vertigo persisted, she became normotensive (120/80 mm Hg) on March 28, 1976, and was discharged. However, during the next 30 years, she continued to experience fatigue, generalized weakness, headache, insomnia, depression, dysmorphopsias, paresthesias, lightheadedness, dizziness and syncope, and labile hypotension. She describes "fatigue so severe that I have no energy for days," "staggering when getting up," "inability to produce words at times," and "spells of loss of consciousness" (up to 15 minutes in duration, as noted by her husband). In 1992, a magnetic resonance imaging scan of the brain demonstrated periventricular hyperintense signals. As of February 2006, her symptoms persist.

Conclusions

Auditory or vestibular dysfunction may develop in patients with Lassa fever, and tinnitus, autophony, hearing loss, dizziness, vertigo, nystagmus, and ataxia have been reported (,). In their review of a 1989 nosocomial Lassa fever outbreak in a Nigerian hospital, Fisher-Hoch et al. () noted a high fever in the index patient, who was taken to surgery on February 25. The patient bled profusely and died later that night. The surgical nurse and a student nurse who washed blood-soaked cloths both became ill with febrile illnesses on March 7. Both became serologically positive for Lassa fever virus. The surgical nurse was traced to her village, where she was found to be almost totally deaf and severely ataxic. Onset of deafness among patients with Lassa fever is a feature of the convalescent phase rather than the acute phase of the illness (). Deafness was first reported as a complication of Lassa fever by White () and Henderson () in 1972. White noted that during a 1970 nosocomial hospital outbreak in Jos, Nigeria, deafness occurred in 4 of 23 hospitalized patients; a fifth patient reported intermittent tinnitus, and 3 patients experienced dizziness. Among the now 24 reported patients with imported Lassa fever worldwide (1969–2004, Table A1, our 26-year-old aid worker is the only patient whose clinical course has been complicated by sensorineural deafness. Our second patient's clinical course has been remarkable for an array of acute and chronic neurologic and neuropsychiatric complications, including left-sided facial weakness, right-sided Babinski reflex, headache, paresthesias, vertigo, syncope, dysmorphopsias, fatigue, insomnia, and depression. Rose (,) reported a 1955–1956 outbreak of encephalomyelitis in Sierra Leone, which may represent the earliest recorded clinical description of Lassa fever; remarkably, vertigo developed in 30 of his 45 patients. Solbrig and McCormick () reported that neuropsychiatric sequelae of Lassa fever have included sleep disorders (e.g., insomnia), asthenia, multiple somatic complaints, psychosis, hallucinations, personality disorders, severe adjustment reactions, dementia, mania, and depression. Finally, our patient's ongoing labile hypotension may represent Lassa fever–induced damage to the brain stem with resultant autonomic dysfunction. Since our patient's array of persistent neurologic and neuropsychiatric symptoms have not changed, improved, or progressed since her episode of Lassa fever, we believe that they all may represent sequelae of Lassa fever–induced damage to the brain.
Table A1

Patients with imported Lassa fever, worldwide, 1969–2004

Year of importFromToOccupationClinical outcomeReference
1969NigeriaUnited StatesNurseSurvived (10)
1971Sierra LeoneUnited KingdomNurseSurvived (11)
1971Sierra LeoneUnited KingdomPhysicianSurvived (11)
1972Sierra LeoneUnited KingdomNurseSurvived (12)
1974NigeriaGermanyPhysicianSurvived (13)
1975NigeriaUnited KingdomPhysicianDied (13)
1975Sierra LeoneUnited StatesAid workerSurvived
1976Sierra LeoneUnited StatesAid workerSurvived (14)
1976NigeriaUnited KingdomEngineerSurvived (15)
1980Upper VoltaNetherlandsAid workerSurvived (16)
1981NigeriaUnited KingdomTeacherSurvived (17)
1982NigeriaUnited KingdomDiplomatSurvived (18)
1984Sierra LeoneUnited KingdomGeologistSurvived (19)
1985Sierra LeoneUnited KingdomNurseSurvived (20)
1987Sierra Leone/LiberiaIsraelEngineerSurvived (21)
1987Sierra LeoneJapanEngineerSurvived (22)
1989NigeriaCanadaAgricultural specialistSurvived (23)
1989NigeriaUnited StatesEngineerDied (24)
2000Cotê d'Ivoire/Burkina Faso/GhanaGermanyStudentDied (25)
2000Sierra LeoneUnited KingdomPeacekeeperDied (25)
2000NigeriaGermanyUnknownDied (25)
2000Sierra LeoneNetherlandsPhysicianDied (25)
2003Sierra LeoneUnited KingdomPeacekeeperSurvived (26)
2004Sierra Leone/LiberiaUnited StatesBusinessmanDied (27)
Table

Patients with imported Lassa fever who were hospitalized in the United States*

Patient no.Year of importFromToClinical manifestations
11969NigeriaNew York, NYFever, malaise, headache, nausea, sore throat, epigastric/right upper quadrant tenderness, pleural effusion, facial/cervical edema, dysphagia, elevated transaminases, cough, dyspnea, pulmonary infiltrates, epiglottal edema, lethargy, nystagmus, lightheadedness, dizziness without vertigo, ataxia, alopecia (2)
21975Sierra LeoneWashington, DCAbdominal pain, diarrhea, fever, headache, myalgia, arthralgia, conjunctival injection, lymphadenopathy, weight loss, pleuritic chest pain, pleural effusion, unilateral deafness
31976Sierra LeoneWashington, DCAbdominal cramps, nausea, vomiting, diarrhea, fatigue, headache, retroorbital pain, neck/back pain, paresthesias, right ear pain, fever, vertigo, syncope, dysmorphopsias, alopecia, weight loss, ecchymoses, insomnia, depression, hypotension, left-sided facial weakness, right-sided Babinski reflex, Weber test lateralized to the left (3)
41989NigeriaChicago, ILShaking chills, fever, sore throat, myalgia, headache, dysphagia, bloody diarrhea, elevated transaminases, hypotension, adult respiratory distress syndrome, death (4)
52004Sierra Leone and LiberiaTrenton, NJChills, fever, sore throat, diarrhea, back pain, adult respiratory distress syndrome, death (1)

*Patients 1–4 are US citizens; patient 5 is a Liberian national.

  18 in total

1.  Lassa fever: response to an imported case.

Authors:  R M Zweighaft; D W Fraser; M A Hattwick; W G Winkler; W C Jordan; M Alter; M Wolfe; H Wulff; K M Johnson
Journal:  N Engl J Med       Date:  1977-10-13       Impact factor: 91.245

2.  Monitoring of clinical and laboratory data in two cases of imported Lassa fever.

Authors:  Herbert Schmitz; Bernhard Köhler; Thomas Laue; Christian Drosten; Peter J Veldkamp; Stephan Günther; Petra Emmerich; Hans P Geisen; Klaus Fleischer; Matthias F C Beersma; Achim Hoerauf
Journal:  Microbes Infect       Date:  2002-01       Impact factor: 2.700

3.  Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings.

Authors:  J D Frame; J M Baldwin; D J Gocke; J M Troup
Journal:  Am J Trop Med Hyg       Date:  1970-07       Impact factor: 2.345

4.  Lassa fever in Britain: an imported case.

Authors:  A W Woodruff; T P Monath; A A Mahmoud; A K Pain; C A Morris
Journal:  Br Med J       Date:  1973-09-22

5.  Lassa fever. A study of 23 hospital cases.

Authors:  H A White
Journal:  Trans R Soc Trop Med Hyg       Date:  1972       Impact factor: 2.184

6.  Managing Lassa fever.

Authors:  R T Emond; W R Weir; E T Bowen; G Lloyd; T Southee
Journal:  Lancet       Date:  1984-10-20       Impact factor: 79.321

7.  Lassa fever: retrospective diagnosis of two patients seen in Great Britain in 1971.

Authors:  H M Gilles; J C Kent
Journal:  Br Med J       Date:  1976-11-13

8.  Lassa fever. Virological and serological studies.

Authors:  B E Henderson; G W Gary; R E Kissling; J D Frame; D E Carey
Journal:  Trans R Soc Trop Med Hyg       Date:  1972       Impact factor: 2.184

9.  Imported Lassa fever--New Jersey, 2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-10-01       Impact factor: 17.586

10.  A case of Lassa fever: experience at St Thomas's Hospital.

Authors:  C B Cooper; W R Gransden; M Webster; M King; M O'Mahony; S Young; J E Banatvala
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-09
View more
  65 in total

1.  Persistence of Lassa Virus Associated With Severe Systemic Arteritis in Convalescing Guinea Pigs (Cavia porcellus).

Authors:  David X Liu; Donna L Perry; Lisa Evans DeWald; Yingyun Cai; Katie R Hagen; Timothy K Cooper; Louis M Huzella; Randy Hart; Amanda Bonilla; John G Bernbaum; Krisztina B Janosko; Ricky Adams; Reed F Johnson; Jens H Kuhn; Matthias J Schnell; Ian Crozier; Peter B Jahrling; Juan C de la Torre
Journal:  J Infect Dis       Date:  2019-05-05       Impact factor: 5.226

2.  Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates.

Authors:  Igor S Lukashevich; Ricardo Carrion; Maria S Salvato; Keith Mansfield; Kathleen Brasky; Juan Zapata; Cristiana Cairo; Marco Goicochea; Gia E Hoosien; Anysha Ticer; Joseph Bryant; Harry Davis; Rasha Hammamieh; Maria Mayda; Marti Jett; Jean Patterson
Journal:  Vaccine       Date:  2008-08-08       Impact factor: 3.641

3.  Protection From Lethal Lassa Disease Can Be Achieved Both Before and After Virus Exposure by Administration of Single-Cycle Replicating Lassa Virus Replicon Particles.

Authors:  Markus H Kainulainen; Jessica R Spengler; Stephen R Welch; JoAnn D Coleman-McCray; Jessica R Harmon; Florine E M Scholte; Cynthia S Goldsmith; Stuart T Nichol; César G Albariño; Christina F Spiropoulou
Journal:  J Infect Dis       Date:  2019-09-13       Impact factor: 5.226

4.  Case Report: Imported Case of Lassa Fever - New Jersey, May 2015.

Authors:  Prathit A Kulkarni; Debra Chew; Manal Youssef-Bessler; Hanaa A Hamdi; Lindsay A Montoya; Kimberly B Cervantes; Nicole L Mazur; Diana Lucas; Julia W Wells; David Cennimo; Anne Sutherland; Linda M Di Domenico; Lincoln P Miller; Frantz Pierre-Louis; Gregory Rokosz; Atif Nazir; Marie A de Perio; Luis Lowe; Craig Manning; Kenneth R Mead; Bryan E Christensen; César G Albariño; Ute Ströher; Maleeka Glover; Edward I Lifshitz; Christina G Tan; Pierre E Rollin; Shereen Semple
Journal:  Am J Trop Med Hyg       Date:  2018-10       Impact factor: 2.345

5.  A recently isolated Lassa virus from Mali demonstrates atypical clinical disease manifestations and decreased virulence in cynomolgus macaques.

Authors:  David Safronetz; James E Strong; Friederike Feldmann; Elaine Haddock; Nafomon Sogoba; Douglas Brining; Thomas W Geisbert; Dana P Scott; Heinz Feldmann
Journal:  J Infect Dis       Date:  2013-01-09       Impact factor: 5.226

6.  SAR studies of 4-acyl-1,6-dialkylpiperazin-2-one arenavirus cell entry inhibitors.

Authors:  Michael B Plewe; Landon R Whitby; Shibani Naik; Eric R Brown; Nadezda V Sokolova; Vidyasagar Reddy Gantla; Joanne York; Jack H Nunberg; Lihong Zhang; Birte Kalveram; Alexander N Freiberg; Dale L Boger; Greg Henkel; Ken McCormack
Journal:  Bioorg Med Chem Lett       Date:  2019-08-24       Impact factor: 2.823

7.  Moving Lassa Fever Research and Care Into the 21st Century.

Authors:  William A Fischer; David A Wohl
Journal:  J Infect Dis       Date:  2017-06-15       Impact factor: 5.226

8.  Design of peptide-based epitope vaccine and further binding site scrutiny led to groundswell in drug discovery against Lassa virus.

Authors:  Mohammad Uzzal Hossain; Taimur Md Omar; Arafat Rahman Oany; K M Kaderi Kibria; Abu Zaffar Shibly; Md Moniruzzaman; Syed Raju Ali; Md Monirul Islam
Journal:  3 Biotech       Date:  2018-01-16       Impact factor: 2.406

9.  Lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues.

Authors:  Ricardo Carrion; Kathleen Brasky; Keith Mansfield; Curtis Johnson; Monica Gonzales; Anysha Ticer; Igor Lukashevich; Suzette Tardif; Jean Patterson
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

10.  Influence of RNA Binding on the Structure and Dynamics of the Lassa Virus Nucleoprotein.

Authors:  Jason G Pattis; Eric R May
Journal:  Biophys J       Date:  2016-03-29       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.